Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Antígenos para la detección específica de anticuerpos contra Coxiella burnetii y algunas especies de chlamidya y rickettsia con aplicación en agricultura, ganadería, mataderos, producción de leche, procesamiento de piel de animales y veterinaria

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOSK20151016001
Publicado:
24/10/2015
Caducidad:
23/10/2016
Resumen:
Un instituto de investigación eslovaco ha desarrollado nuevos antígenos corpusculares de Coxiella burnetii y algunas especies de chlamidya y rickettsia. Estos antígenos se han diseñado para medir de forma precisa anticuerpos contra estas bacterias en muestras de suero, plasma y leche de animales y humanos. También pone a disposición una vacuna corpuscular eficiente para la profilaxis contra coxielosis en ganado. El instituto está interesado en establecer acuerdos de licencia o joint venture.

Details

Tittle:
Antigens for specific detection of antibodies against Coxiella burnetii, and some chlamydial and rickettsia species with practical use in agriculture, livestock production, slaughterhouses, milk production, animal skin-processing and veterinary industries
Summary:
A Slovak institute has developed new highly purified corpuscular antigens of Coxiella burnetii, and some chlamydial and rickettsial species. They were designed for accurate measurement of antibodies against these bacteria in serum, plasma and milk samples of animals and humans. An efficient corpuscular vaccine for prophylaxis against coxiellosis in livestock is also available. These products are open for license and/or joint venture.
Description:
A Slovak institute active in virology and microbiology has developed new highly purified corpuscular antigens enabling rapid, simple, sensitive and specific detection of antibodies against Coxiella burnetii and some chlamydial and rickettsial species in serum, plasma and milk samples of animals and in human.

Antigens are white or slightly yellow, uniformly turbid suspensions of highly purified bacterial cells in phosphate buffered saline with thiomersal or phenol as a preservative. However, a sediment may be formed after a longer period of storage it can easily be re-suspended by shaking.

Here is the list of developed antigens:

Antigens for Q fever serodiagnotics:
Complement fixation (CF) test
· Coxiella burnetii phase I antigen for CF test
· Coxiella burnetii phase II antigen for CF test
Enzyme-linked immunosorbent assay (ELISA)
· Coxiella burnetii phase I antigen for ELISA test
· Coxiella burnetii phase II antigen for ELISA test


Antigens for chlamydiosis serodiagnotics
Complement fixation (CF) test
· Chlamydia psittaci antigen for CF test
· Chlamydia abortus antigen for CF test
Enzyme-linked immunosorbent assay (ELISA)
· Chlamydia psittaci antigen for ELISA test
· Chlamydia abortus antigen for ELISA test

Antigens for spoted fever group rickettsiosis serodiagnotics
Enzyme-linked immunosorbent assay (ELISA)
· Rickettsia conorii antigen for ELISA test
· Rickettsia akari antigen for ELISA test
· Rickettsia slovaca antigen for ELISA test

Domain of application of this technology:
Professions at high exposition risk: personnel in agriculture, life stock production, slaughterhouses, milk production, animal skin-processing industry, veterinarians and laboratory personnel.

The research institute is looking for cooperation via joint venture agreement (the partner for this specific technological project is sought) or via license agreement (the research institute is offering a license). These types of cooperation have been chosen because they are fitting todays need of the company in the best possible way.
Advantages and Innovations:
Rapid antigen detection testing would allow a more rational use of antibiotics and would prevent adverse effects of antibiotics on the patient, antibiotic resistance emergence and the growth of inefficient health expense.
Stage of Development:
Field tested/evaluated
IPs:
Secret know-how

Partner sought

Type and Role of Partner Sought:
- Type of partner sought: The Slovak research institute is looking especially for these kind of partners: institutes and institutions - hospitals, health centres, veterinary institutes, regional veterinary stations, etc.

- Field of activity: health, veterinary, agriculture

- Role of partner: The research institute is looking for cooperation via joint venture agreement (the research institute has a specific technological project and is looking for a partner) or via license agreement (the research institute is offering a license).

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
Czech
English
Slovak

Keywords

Technology Keywords:
06001001 Bioestadística, epidemiología
06001005 Diagnósticos, diagnosis
06002008 Microbiología
06001018 Virus, virología / antibióticos / bacteriología